Samsung Biologics Co.,Ltd.
207940
Rangering i aksjer
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Aksjekurs
$1,028.49
Markedsverdi
$47.88B
Endring (1 dag)
-3.67%
Endring (1 år)
-18.37%
Land
KR
Handel Samsung Biologics Co.,Ltd. (207940)
Kategori
Healthcare
Historikk for aksjesplitt for Samsung Biologics Co.,Ltd. (207940)
Aksjen Samsung Biologics Co.,Ltd. (symbol: 207940) har gjennomgått totalt 1 aksjesplitt.
Den nyeste splittelsen skjedde Oct 30, 2025.
Én 207940-aksje kjøpt før Oct 30, 2025 tilsvarer i dag 0.650391 207940-aksjer.
Den nyeste splittelsen skjedde Oct 30, 2025.
Én 207940-aksje kjøpt før Oct 30, 2025 tilsvarer i dag 0.650391 207940-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| 2025-10-30 | 650391:1000000 | x0.650391 | x0.650391 |
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
